If life with ulcerative colitis feels like it revolves around constant planning, pain, and uncertainty, explore a different route with the LATITUDE UC Study.
The LATITUDE UC Study is evaluating the efficacy and safety of an investigational oral treatment for ulcerative colitis (UC). Participants will receive the investigational treatment or a placebo (a substance that looks like the investigational treatment but does not contain any active ingredients) while completing various study tests and procedures.
Participants originally assigned to placebo will have the opportunity to switch to the investigational treatment after the 12-week induction period. All study treatments will be given as oral pills.
Neither participants nor the study staff will know if participants are receiving the investigational treatment or a placebo. Participants will attend up to 14 scheduled study visits (and any additional study visits if needed) over the course of about a year.